{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T01:42:41Z","timestamp":1782783761126,"version":"3.54.5"},"reference-count":69,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T00:00:00Z","timestamp":1565654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc."}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0220921","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T17:30:45Z","timestamp":1565717445000},"page":"e0220921","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":34,"title":["Cost-effectiveness analysis of universal varicella vaccination in Turkey using a dynamic transmission model"],"prefix":"10.1371","volume":"14","author":[{"given":"Lara J.","family":"Wolfson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3226-7231","authenticated-orcid":true,"given":"Vincent J.","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8128-6623","authenticated-orcid":true,"given":"Matthew","family":"Pillsbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zafer","family":"Kurug\u00f6l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuneyt","family":"Yardimci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Kyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ener Cagri","family":"Dinleyici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,8,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S1474-4422(07)70267-3","article-title":"The neurotropic herpes viruses: herpes simplex and varicella-zoster","volume":"6","author":"I Steiner","year":"2007","journal-title":"Lancet Neurol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e20153741","DOI":"10.1542\/peds.2015-3741","article-title":"Global varicella vaccine effectiveness: a meta-analysis","volume":"137","author":"M Marin","year":"2016","journal-title":"Pediatrics"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/aje\/kwv240","article-title":"The epidemiology of herpes zoster after varicella immunization under different biological hypotheses: perspectives from mathematical modeling","volume":"183","author":"G Guzzetta","year":"2016","journal-title":"Am J Epidemiol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e66485","DOI":"10.1371\/journal.pone.0066485","article-title":"Herpes zoster risk reduction through exposure to chickenpox patients: a systematic multidisciplinary review","volume":"8","author":"B Ogunjimi","year":"2013","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1080\/14760584.2018.1538801","article-title":"Understanding the role of exogenous boosting in modeling varicella vaccination","volume":"17","author":"SE Talbird","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"e1389","DOI":"10.1542\/peds.2012-3303","article-title":"Long-term effectiveness of varicella vaccine: a 14-year, prospective cohort study","volume":"131","author":"R Baxter","year":"2013","journal-title":"Pediatrics"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1093\/infdis\/jit405","article-title":"Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005\u20132009","volume":"208","author":"S Weinmann","year":"2013","journal-title":"J Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1017\/S0950268800004714","article-title":"Modelling the impact of immunization on the epidemiology of varicella zoster virus","volume":"125","author":"M Brisson","year":"2000","journal-title":"Epidemiol Infect"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1186\/s12889-015-1861-8","article-title":"Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries","volume":"15","author":"O Damm","year":"2015","journal-title":"BMC Public Health"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.vaccine.2009.10.086","article-title":"Comparative varicella vaccine effectiveness during outbreaks in day-care centres","volume":"28","author":"M Spackova","year":"2010","journal-title":"Vaccine"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajic.2017.07.029","article-title":"Incidence rate of breakthrough varicella observed in healthy children after 1 or 2 doses of varicella vaccine: Results from a meta-analysis","volume":"46","author":"S Zhu","year":"2018","journal-title":"Am J Infect Control"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"17192","DOI":"10.1038\/s41598-018-35451-y","article-title":"Epidemiology of breakthrough varicella after the implementation of a universal varicella vaccination program in Taiwan, 2004\u20132014","volume":"8","author":"HY Cheng","year":"2018","journal-title":"Sci Rep"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.24953\/turkjped.2018.01.008","article-title":"Outbreak of varicella in preschool children despite one-dose vaccination","volume":"60","author":"Z Kurugol","year":"2018","journal-title":"Turk J Pediatr"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00431-011-1650-z","article-title":"The epidemiology and economic impact of varicella-related hospitalizations in Turkey from 2008 to 2010: a nationwide survey during the pre-vaccine era (VARICOMP study)","volume":"171","author":"EC Dinleyici","year":"2012","journal-title":"Eur J Pediatr"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1016\/j.vaccine.2015.06.029","article-title":"Children with breakthrough varicella infection requiring hospitalization in Turkey (VARICOMP Study 2008\u20132013)","volume":"33","author":"EC Dinleyici","year":"2015","journal-title":"Vaccine"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e475","DOI":"10.1016\/j.ijid.2011.03.016","article-title":"Varicella rates among unvaccinated and one-dose vaccinated healthy children in Izmir, Turkey","volume":"15","author":"Z Kurugol","year":"2011","journal-title":"Int J Infect Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/INF.0000000000000821","article-title":"Impact of the US two-dose varicella vaccination program on the epidemiology of varicella outbreaks: data from nine states, 2005\u20132012","volume":"34","author":"J Leung","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1006\/bulm.1999.0126","article-title":"Modeling the effects of varicella vaccination programs on the incidence of chickenpox and shingles","volume":"61","author":"MC Schuette","year":"1999","journal-title":"Bull Math Biol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1016\/S0264-410X(00)00100-6","article-title":"Analysis of varicella vaccine breakthrough rates: implications for the effectiveness of immunisation programmes","volume":"18","author":"M Brisson","year":"2000","journal-title":"Vaccine"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1016\/j.vaccine.2010.02.079","article-title":"Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster","volume":"28","author":"M Brisson","year":"2010","journal-title":"Vaccine"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.vaccine.2011.01.037","article-title":"Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England","volume":"29","author":"AJ van Hoek","year":"2011","journal-title":"Vaccine"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0025-5564(97)00014-X","article-title":"An age-structured model for pertussis transmission","volume":"145","author":"HW Hethcote","year":"1997","journal-title":"Math Biosci"},{"key":"ref23","unstructured":"United Nations Population Division. Population by age groups 2017 [cited 9 May 2019]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/esa.un.org\/unpd\/wpp\/Download\/Standard\/Population\/\" xlink:type=\"simple\">http:\/\/esa.un.org\/unpd\/wpp\/Download\/Standard\/Population\/<\/ext-link>."},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e60732","DOI":"10.1371\/journal.pone.0060732","article-title":"Perspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries","volume":"8","author":"P Poletti","year":"2013","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"20142509","DOI":"10.1098\/rspb.2014.2509","article-title":"The impact of demographic changes on the epidemiology of herpes zoster: Spain as a case study","volume":"282","author":"V Marziano","year":"2015","journal-title":"Proc Biol Sci"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1098\/rspb.1993.0075","article-title":"Imperfect vaccines and herd immunity to HIV","volume":"253","author":"AR McLean","year":"1993","journal-title":"Proc Biol Sci"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.inf.0000109287.97518.67","article-title":"Ten year follow-up of healthy children who received one or two injections of varicella vaccine","volume":"23","author":"B Kuter","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/01.inf.0000172902.25009.a1","article-title":"Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children","volume":"24","author":"H Shinefield","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.clinthera.2015.01.006","article-title":"Cost-effectiveness of routine varicella vaccination using the measles, mumps, rubella and varicella vaccine in France: an economic analysis based on a dynamic transmission model for varicella and herpes zoster","volume":"37","author":"KJ Littlewood","year":"2015","journal-title":"Clin Ther"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e1005697","DOI":"10.1371\/journal.pcbi.1005697","article-title":"Projecting social contact matrices in 152 countries using contact surveys and demographic data","volume":"13","author":"K Prem","year":"2017","journal-title":"PLoS Comput Biol"},{"key":"ref31","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198526629.001.0001","article-title":"Decision modelling for health economic evaluation","author":"AH Briggs","year":"2006"},{"key":"ref32","unstructured":"United Nations Department of Economic and Social Affairs Population Division. Births by age of mother 2017 [cited 9 May 2019]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/esa.un.org\/unpd\/wpp\/DVD\/Files\/1_Indicators\" xlink:type=\"simple\">https:\/\/esa.un.org\/unpd\/wpp\/DVD\/Files\/1_Indicators<\/ext-link> (Standard)\/EXCEL_FILES\/2_Fertility\/WPP2017_FERT_F06_BIRTHS_BY_AGE_OF_MOTHER.xlsx."},{"key":"ref33","unstructured":"United Nations Department of Economic and Social Affairs Population Division. Annual population by age\u2014both sexes 2017 [cited 9 May 2019]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/esa.un.org\/unpd\/wpp\/DVD\/Files\/1_Indicators(Standard)\/EXCEL_FILES\/5_Interpolated\/WPP2017_INT_F03_1_POPULATION_BY_AGE_ANNUAL_BOTH_SEXES.xlsx\" xlink:type=\"simple\">https:\/\/esa.un.org\/unpd\/wpp\/DVD\/Files\/1_Indicators(Standard)\/EXCEL_FILES\/5_Interpolated\/WPP2017_INT_F03_1_POPULATION_BY_AGE_ANNUAL_BOTH_SEXES.xlsx<\/ext-link>"},{"key":"ref34","first-page":"185","article-title":"Seroprevalence of mumps, varicella and rubella antibodies in children 1\u201316 years of age in eastern Turkey","volume":"48","author":"MK Gurgoze","year":"2006","journal-title":"Turk J Pediatr"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jiph.2012.10.003","article-title":"Seroprevalence of varicella-zoster virus in the prevaccine era: a population-based study in Izmir, Turkey","volume":"6","author":"S Kose","year":"2013","journal-title":"J Infect Public Health"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1016\/j.vaccine.2008.07.021","article-title":"Cost-effectiveness analysis of universal childhood vaccination against varicella in Brazil","volume":"26","author":"J Valentim","year":"2008","journal-title":"Vaccine"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jinf.2013.06.016","article-title":"A population based study of the epidemiology of Herpes Zoster and its complications","volume":"67","author":"D Weitzman","year":"2013","journal-title":"J Infect"},{"key":"ref38","unstructured":"US Internal Revenue Service (IRS). Yearly average currency exchange rates [cited 9 May 2019]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.irs.gov\/individuals\/international-taxpayers\/yearly-average-currency-exchange-rates\" xlink:type=\"simple\">https:\/\/www.irs.gov\/individuals\/international-taxpayers\/yearly-average-currency-exchange-rates<\/ext-link>"},{"key":"ref39","unstructured":"World Health Organization (WHO). WHO vaccine-preventable diseases: monitoring system. 2018 global summary: Turkey 2018 [cited 9 May 2019]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/countries?countrycriteria%5Bcountry%5D%5B%5D=TUR&commit=OK\" xlink:type=\"simple\">http:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/countries?countrycriteria%5Bcountry%5D%5B%5D=TUR&amp;commit=OK<\/ext-link>"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.clinthera.2014.12.017","article-title":"The impact of 2-dose routine measles, mumps, rubella, and varicella vaccination in France on the epidemiology of varicella and zoster using a dynamic model with an empirical contact matrix","volume":"37","author":"MJ Ouwens","year":"2015","journal-title":"Clin Ther"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1186\/s12889-016-3738-x","article-title":"Coverage, efficacy or dosing interval: which factor predominantly influences the impact of routine childhood vaccination for the prevention of varicella? A model-based study for Italy","volume":"16","author":"K Holl","year":"2016","journal-title":"BMC Public Health"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12879-019-3759-z","article-title":"The impact of childhood varicella vaccination on the incidence of herpes zoster in the general population: modelling the effect of exogenous and endogenous varicella-zoster virus immunity boosting","volume":"19","author":"C Sauboin","year":"2019","journal-title":"BMC Infect Dis"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0140-6736(12)61461-5","article-title":"Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial","volume":"383","author":"R Prymula","year":"2014","journal-title":"Lancet"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1128\/CVI.00645-13","article-title":"Varicella and varicella vaccination","volume":"21","author":"SH Oh","year":"2014","journal-title":"South Korea. Clin Vaccine Immunol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.3346\/jkms.2016.31.12.1897","article-title":"Effectiveness of varicella vaccination program in preventing laboratory-confirmed cases in children in Seoul, Korea","volume":"31","author":"YH Lee","year":"2016","journal-title":"J Korean Med Sci"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1080\/21645515.2016.1190056","article-title":"Seropositivity of Varicella zoster virus in vaccinated Korean children and MAV vaccine group","volume":"12","author":"UY Choi","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"e2017053","DOI":"10.4178\/epih.e2017053","article-title":"Vaccination history in elementary school children enrolled in the varicella epidemic investigations held in Jeju-si, Korea in the first half of 2017","volume":"39","author":"HS Oh","year":"2017","journal-title":"Epidemiol Health"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"295","DOI":"10.26719\/2018.24.3.295","article-title":"Seroprevalence and social determinants of varicella in Turkey","volume":"24","author":"CH Hekimo\u011flu","year":"2018","journal-title":"East Mediterr Health J"},{"key":"ref49","first-page":"324","article-title":"Prevalence of maternal measles, rubella, mumps and varicella antibodies in the first six months of life","volume":"52","author":"E Devecio\u011flu","year":"2018","journal-title":"Mikrobiyol Bul"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1272\/jnms.79.453","article-title":"Susceptibility to measles, rubella, mumps, and varicella-zoster viruses among healthcare workers","volume":"79","author":"C Aypak","year":"2012","journal-title":"J Nippon Med Sch"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1365-3016.2010.01180.x","article-title":"Seroepidemiology of varicella-zoster virus and reliability of varicella history in Turkish children, adolescents and adults","volume":"25","author":"G Koturoglu","year":"2011","journal-title":"Paediatr Perinat Epidemiol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/tropej\/fmh102","article-title":"Varicella zoster seroprevalence in children less than 5 years old","volume":"51","author":"S Ozkan","year":"2005","journal-title":"J Trop Pediatr"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.healthpol.2004.03.008","article-title":"Seroepidemiology of varicella-zoster virus infection in a cosmopolitan city (Erzurum) in the eastern Turkey","volume":"72","author":"H Alp","year":"2005","journal-title":"Health Policy"},{"key":"ref54","first-page":"69","article-title":"Varicella-zoster virus seroprevalence in children between 0\u201315 years old","volume":"38","author":"S Savas","year":"2004","journal-title":"Mikrobiyol Bul"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0264-410X(01)00459-5","article-title":"Varicella seroprevalence in a random sample of the Turkish population","volume":"20","author":"G Kanra","year":"2002","journal-title":"Vaccine"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3109\/01443615.2015.1127905","article-title":"Congenital varicella syndrome: A systematic review","volume":"36","author":"KH Ahn","year":"2016","journal-title":"J Obstet Gynaecol"},{"key":"ref57","first-page":"260","article-title":"Frequency of congenital varicella syndrome in a prospective cohort of 347 pregnant women","volume":"100","author":"JH Harger","year":"2002","journal-title":"Obstet Gynecol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s15010-018-1150-4","article-title":"Epidemiology, management and outcome of varicella in pregnancy: a 20-year experience at the Tuscany Reference Centre for Infectious Diseases in Pregnancy","volume":"46","author":"M Trotta","year":"2018","journal-title":"Infection"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jcv.2015.07.301","article-title":"Management of varicella-zoster virus primary infection during pregnancy: A national survey of practice","volume":"72","author":"G Benoit","year":"2015","journal-title":"J Clin Virol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1016\/S0264-410X(01)00044-5","article-title":"The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales","volume":"19","author":"WJ Edmunds","year":"2001","journal-title":"Vaccine"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.vaccine.2011.11.026","article-title":"The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom","volume":"30","author":"AJ van Hoek","year":"2012","journal-title":"Vaccine"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jval.2018.08.005","article-title":"Economic analysis of vaccination programs","volume":"21","author":"J Mauskopf","year":"2018","journal-title":"Value in Health"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4161\/hv.34311","article-title":"Impact of universal vaccination against varicella in Italy","volume":"11","author":"A Bechini","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"ref64","first-page":"E120","article-title":"Impact of vaccination programs against measles, varicella and meningococcus C in Italy and in Tuscany and public health policies in the last decades","volume":"59","author":"A Bechini","year":"2018","journal-title":"J Prev Med Hyg"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12916-018-1094-7","article-title":"The impact of demographic changes, exogenous boosting and new vaccination policies on varicella and herpes zoster in Italy: a modelling and cost-effectiveness study","volume":"16","author":"A Melegaro","year":"2018","journal-title":"BMC Med"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"20132676","DOI":"10.1098\/rspb.2013.2676","article-title":"Deciphering the relative weights of demographic transition and vaccination in the decrease of measles incidence in Italy","volume":"281","author":"S Merler","year":"2014","journal-title":"Proc Biol Sci"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"e1006334","DOI":"10.1371\/journal.pcbi.1006334","article-title":"Modeling the impact of changes in day-care contact patterns on the dynamics of varicella transmission in France between 1991 and 2015","volume":"14","author":"V Marziano","year":"2018","journal-title":"PLoS Comput Biol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"e004833","DOI":"10.1136\/bmjopen-2014-004833","article-title":"Systematic review of incidence and complications of herpes zoster: towards a global perspective","volume":"4","author":"K Kawai","year":"2014","journal-title":"BMJ Open"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/cid\/cir436","article-title":"Does monastic life predispose to the risk of Saint Anthony&apos;s fire (herpes zoster)?","volume":"53","author":"J Gaillat","year":"2011","journal-title":"Clin Infect Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0220921","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T23:53:26Z","timestamp":1721606006000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0220921"}},"subtitle":[],"editor":[{"given":"Georges M.G.M.","family":"Verjans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,8,13]]},"references-count":69,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0220921","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,13]]}}}